About Shanghai Semero Biotechnology
Shanghai Semero Biotechnology is a company based in Shanghai (China) founded in 2014.. Shanghai Semero Biotechnology has raised $20.76 million across 2 funding rounds from investors including Tianrui Fengnian, Hrincinerator and Guanzi Venture Capital. Shanghai Semero Biotechnology operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.76 M (USD)
in 2 rounds
-
Latest Funding Round
$20.76 M (USD), Series C
Nov 08, 2022
-
Investors
Tianrui Fengnian
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shanghai Semero Biotechnology
Shanghai Semero Biotechnology has successfully raised a total of $20.76M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $20.76 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $20.8M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series C - Shanghai Semero Biotechnology | Valuation | Tianrui Fengnian Private Equity Fund | |
| Oct, 2021 | Amount | Series B - Shanghai Semero Biotechnology | Valuation | GF Xinde Investment Management |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shanghai Semero Biotechnology
Shanghai Semero Biotechnology has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Tianrui Fengnian, Hrincinerator and Guanzi Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund management services are provided by the company.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shanghai Semero Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shanghai Semero Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai Semero Biotechnology Comparisons
Competitors of Shanghai Semero Biotechnology
Shanghai Semero Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| domain | founded_year | HQ Location |
Drug development and preclinical services are provided by Tigermed.
|
|
| domain | founded_year | HQ Location |
Clinical trial services to biopharma sector are provided.
|
|
| domain | founded_year | HQ Location |
Steroids for Duchenne muscular dystrophy treatment are developed.
|
|
| domain | founded_year | HQ Location |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
|
| domain | founded_year | HQ Location |
Contract research on infectious disease models is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shanghai Semero Biotechnology
Frequently Asked Questions about Shanghai Semero Biotechnology
When was Shanghai Semero Biotechnology founded?
Shanghai Semero Biotechnology was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Where is Shanghai Semero Biotechnology located?
Shanghai Semero Biotechnology is headquartered in Shanghai, China.
Is Shanghai Semero Biotechnology a funded company?
Shanghai Semero Biotechnology is a funded company, having raised a total of $20.76M across 2 funding rounds to date.
What does Shanghai Semero Biotechnology do?
Founded in 2014, Shanghai Semero Biotechnology is based in Shanghai, China, and operates within the biotechnology sector. Preclinical services are delivered, encompassing target validation, medicinal chemistry, in vitro screening, and animal model evaluations. Focus is placed on brain-related disorders, with analgesics utilized as research compounds. Operations support drug discovery processes in this specialized area.
Who are the top competitors of Shanghai Semero Biotechnology?
Who are Shanghai Semero Biotechnology's investors?
Shanghai Semero Biotechnology has 4 investors. Key investors include Tianrui Fengnian, Hrincinerator, Guanzi Venture Capital, and GF Xinde Investment Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.